Hypomagnesemia and hypokalemia affect the action of digoxin and should be corrected in patients receiving this medication (1). We assessed both the frequency of hypomagnesemia and hypokalemia in patients receiving digoxin and the frequency with which these electrolyte abnormalities were identified and appropriately treated. All serum specimens received in our hospital laboratory for digoxin analysis during two months were included in this study. Potassium and magnesium were assayed in each of these specimens, but the results were reported to the requesting physician only if potassium, magnesium, or both had also been ordered. During this interval, 90 requests for digoxin measurements were received for 58 different patients. Hypokalemia [potassium <3.6 mmoIJL (2)] was seen in five samples from four of 58 patients. For all these five specimens a request for potassium measurement was received on the same day as the request for digoxin analysisand an appropriate follow-up (potassium supplementation or a repeat potassium analysisshowing normal concentration) occurred in all cases.
Environmental
Safety Hypomagnesemia and hypokalemia affect the action of digoxin and should be corrected in patients receiving this medication (1). We assessed both the frequency of hypomagnesemia and hypokalemia in patients receiving digoxin and the frequency with which these electrolyte abnormalities were identified and appropriately treated. All serum specimens received in our hospital laboratory for digoxin analysis during two months were included in this study. Potassium and magnesium were assayed in each of these specimens, but the results were reported to the requesting physician only if potassium, magnesium, or both had also been ordered. During this interval, 90 requests for digoxin measurements were received for 58 different patients. Hypokalemia [potassium <3.6 mmoIJL (2)] was seen in five samples from four of 58 patients. For all these five specimens a request for potassium measurement was received on the same day as the request for digoxin analysisand an appropriate follow-up (potassium supplementation or a repeat potassium analysisshowing normal concentration) occurred in all cases.
By contrast, we identified hypomagnesemia [magnesium
<0
.75 mmolfL (3)] in 21 specimens from 13 patients. For only five of these 13 patients (38%) had a magnesium measurement been requested at any time during their hospitalization.
When the decreased magnesium was identified, however, it was properly treated in most cases. Of the five patients known by their physicians to be hypomagnesemic, three received magnesium supplements, one patient's magnesium measurement was repeated and found to be within the reference interval, and one test was repeated and confirmed to be <0.75 mmol/L, but no further action was taken.
Although hypomagnesemia
has been shown to occur frequently in patients receiving digoxin (4), its assay was ordered by physicians much less frequently than was that for potassium. In this study, eight of 13 hypomagnesemic patients were not identified or treated. We think that routinely including magnesium with other "electrolyte" measurements (5, 6) or automatically including magnesium results with digoxin reports will assist in identifying additional patients at risk for the toxic effects of digoxin.
